Intergroup Randomized Phase III Study of Postoperative Oxaliplatin, 5‐Fluorouracil, and Leucovorin Versus Oxaliplatin, 5‐Fluorouracil, Leucovorin, and Bevacizumab for Patients with Stage II or III Rectal Cancer Receiving Preoperative Chemoradiation: A Trial of the ECOG‐ACRIN Research Group (E5204)

BACKGROUND: The addition of bevacizumab to chemotherapy improved outcomes for patients with metastatic colon cancer. E5204 was designed to test whether the addition of bevacizumab to mFOLFOX6, following neoadjuvant chemoradiation and definitive surgery, could improve overall survival (OS) in patient...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Oncologist
Autors principals: Chakravarthy, A. Bapsi, Zhao, Fengmin, Meropol, Neal J., Flynn, Patrick J., Wagner, Lynne I., Sloan, Jeffrey, Diasio, Robert B., Mitchell, Edith P., Catalano, Paul, Giantonio, Bruce J., Catalano, Robert B., Haller, Daniel G., Awan, Rashid A., Mulcahy, Mary F., O'Brien, Timothy E., Santala, Roger, Cripps, Christine, Weis, John R., Atkins, James N., Leichman, Cynthia G., Petrelli, Nicholas J., Sinicrope, Frank A., Brierley, James D., Tepper, Joel E., O'Dwyer, Peter J., Sigurdson, Elin R., Hamilton, Stanley R., Cella, David, Benson, Al B.
Format: Artigo
Idioma:Inglês
Publicat: John Wiley & Sons, Inc. 2019
Matèries:
Gastrointestinal Cancer
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7216434/
https://ncbi.nlm.nih.gov/pubmed/31852811
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2019-0437
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars